In the Spotlight - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

In the Spotlight
New product reviews for November 2012.

Pharmaceutical Technology
Volume 36, Issue 11, pp. 24

Manufacturing process intelligent software helps improve process predictability



The latest version of Aegis's Discoverant software can perform data aggregation, investigational analytics, and process modeling to improve process predictability and product quality. Discoverant 4.2 includes new features that were developed following input from Aegis customers, such as simplified user management and authentication with network-based group management, enhanced support for global collaboration across multiple time zones, new administrative reports, and greater control over query tools for easier model management. In addition, advanced analysis and data collection are made possible via the software's InVision and PRIMR features.

Aegis Analytical Corp.
http://aegiscorp.com/
Software is available worldwide

Asset management system offers condition-based monitoring capabilities



Honeywell Process Solutions' Asset Manager R410 version offers real-time, condition-based monitoring of equipment to assist in maintenance and reliability planning. The system integrates with IBM's Maximo and SAP enterprise asset management and computerized maintenance management systems. This integration allows maintenance and reliability planners to review the status and priority of equipment health and the severity of any failures, assign resources as well as raise and track work orders directly from Asset Manager. In addition, Honeywell's newest version of its Field Advisor tool, which helps mobile workers prioritize and execute field tasks, has been refreshed to provide efficient automation for rounds and inspections.

Honeywell Process Solutions
http://www.honeywellprocess.com/
System is available worldwide


ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
How does your company apply quality-by-design (QbD) principles to manufacturing processes?
To all processes for both new and legacy products
To all process for new products only
To select process for new products only
To select processes for both new and legacy products
Do not use QbD
To all processes for both new and legacy products
18%
To all process for new products only
13%
To select process for new products only
22%
To select processes for both new and legacy products
22%
Do not use QbD
24%
View Results
UPCOMING CONFERENCES

Programs for Investigational and Pre-Launch Drugs
Philadelphia, PA
July 17-18, 2013
Request Brochure

Strategic Pipeline Planning & Portfolio Valuation
Philadelphia, PA
August 13-14, 2013
Request Brochure

MES 2013 - Forum on Manufacturing Execution Systems
Philadelphia, PA
August 14-15, 2013
Request Brochure

Mobile Innovation for the Life Sciences Industry
Philadelphia, PA
August 20-21, 2013
Request Brochure

See All Conferences >>

Eric Langer Outsourcing Outlook Eric LangerOutsourcing's Modest Role as a Cost-Containment Strategy
Patricia Van Arnum Ingredients Insider Patricia Van ArnumIntellectual Property Battles in Solid-State Chemistry
Nathan Jessop Industry Insider Nathan Jessop Campaign Against Counterfeit Drugs Continues
Lynn Torbeck Statistical Solutions Lynn D. TorbeckCompositing Samples and the Risk to Product Quality
 More
Inadequate Access to Medicines Puts EU at Risk
FDA Offers Insight on QbD for Modified-Release Products
Global Biosimilars Market to Reach $2.445 Billion in 2013
Adapting to Change
AstraZeneca and Exco InTouch Collaborate to Augment Current COPD Pathways
FindPharma Custom Search
Source: Pharmaceutical Technology,
Click here